|

Lopinavir/Ritonavir in PLWH With High-Grade AIN

RECRUITINGPhase 1Sponsored by University of Wisconsin, Madison
Actively Recruiting
PhasePhase 1
SponsorUniversity of Wisconsin, Madison
Started2023-12-19
Est. completion2027-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05334004

Summary

This study is being done to assess the safety of lopinavir/ritonavir in patients with PLWH with AIN. 30 participants will be recruited and can expect to be on active study for approximately 3 months and long term follow up for 40 weeks.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* willing to provide informed consent
* greater than or equal to 18 years of age
* Diagnosis of biopsy-confirmed HGAIN
* willing to comply with all study procedures

Exclusion Criteria:

* Diagnosis of low-grade anal dysplasia (AIN, low-grade squamous intraepithelial lesion (LSIL)) by HRA.
* CD4 count less than 200 cells/mm\^3 at the time of consideration for entry into the study
* unable to provide informed consent
* Pregnant or breastfeeding female
* Currently receiving systemic chemotherapy or radiation therapy for another cancer.

Conditions2

CancerHigh-Grade Anal Intraepithelial Neoplasia

Interventions1

Lopinavir / Ritonavir

Locations1 site

UW Digestive Health Center Anoscopy Clinic
Madison, Wisconsin, 53705

Find trials near these locations

All trials in Wisconsin

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.